A 1-year surveillance interval is recommended for patients with serrated polyposis syndrome. Serrated polyposis syndrome is a rare condition characterized by multiple or large serrated polyps, including [...]. Patients with serrated polyposis syndrome are at increased risk of colorectal cancer.
Answer
hyperplastic polyps, sessile serrated polyps, traditional serrated adenomas, and possibly also adenomatous polyps
Question
A 1-year surveillance interval is recommended for patients with serrated polyposis syndrome. Serrated polyposis syndrome is a rare condition characterized by multiple or large serrated polyps, including [...]. Patients with serrated polyposis syndrome are at increased risk of colorectal cancer.
Answer
?
Question
A 1-year surveillance interval is recommended for patients with serrated polyposis syndrome. Serrated polyposis syndrome is a rare condition characterized by multiple or large serrated polyps, including [...]. Patients with serrated polyposis syndrome are at increased risk of colorectal cancer.
Answer
hyperplastic polyps, sessile serrated polyps, traditional serrated adenomas, and possibly also adenomatous polyps
If you want to change selection, open original toplevel document below and click on "Move attachment"
Parent (intermediate) annotation
Open it A 1-year surveillance interval is recommended for patients with serrated polyposis syndrome. Serrated polyposis syndrome is a rare condition characterized by multiple or large serrated polyps, including hyperplastic polyps, sessile serrated polyps, traditional serrated adenomas, and possibly also adenomatous polyps. Patients with serrated polyposis syndrome are at increased risk of colorectal cancer.
Original toplevel document (pdf)
owner: ELBOMBARDO - (no access) - MKSAP_17.pdf, p2630
Summary
status
not learned
measured difficulty
37% [default]
last interval [days]
repetition number in this series
0
memorised on
scheduled repetition
scheduled repetition interval
last repetition or drill
Details
No repetitions
Discussion
Do you want to join discussion? Click here to log in or create user.